Royalty Pharma RPRX
$68.45 +$0.73 (+1.08%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $67.91 -0.79%
Open$68.17
Prev close$67.72
Day range$67.95 – $68.83
Volume3.53M
Market cap$30.48B
P/E (TTM)44.7
Dividend yield1.35%
Analyst view
ConsensusBuy
Analysts6
Average target$72.67+6.2% vs. price
- Buy 100%
Low $63.00Now $68.45Avg $72.67High $80.00
Recent rating changes
The last 20 actions on file set price targets from $62.00 to $80.00, averaging $68.37.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 18 Nov 2026 | TD Cowen | BUY | $80.00 |
| 5 Nov 2026 | Morgan Stanley | BUY | $75.00 |
| 5 Nov 2026 | Citi | BUY | $78.00 |
| 4 Nov 2026 | J.P. Morgan | BUY | $74.00 |
| 12 Oct 2026 | Citi | BUY | $70.00 |
| 9 Oct 2026 | BofA Securities | BUY | $63.00 |
| 7 Oct 2026 | Morgan Stanley | BUY | $67.00 |
| 23 Sep 2026 | BofA Securities | BUY | $63.00 |
| 9 Sep 2026 | Citi | BUY | $70.00 |
| 8 Sep 2026 | TD Cowen | BUY | $68.00 |
| 8 Sep 2026 | UBS | BUY | $66.00 |
| 11 Aug 2026 | UBS | BUY | $66.00 |
| 10 Aug 2026 | J.P. Morgan | BUY | $62.00 |
| 6 Aug 2026 | Morgan Stanley | BUY | $65.00 |
| 6 Aug 2026 | Citi | BUY | $70.00 |
| 6 Aug 2026 | Goldman Sachs | BUY | $66.00 |
| 5 Aug 2026 | Morgan Stanley | BUY | $65.00 |
| 15 Jul 2026 | Citi | BUY | $66.00 |
| 13 Jul 2026 | TD Cowen | BUY | $65.00 |
| 10 Jul 2026 | BofA Securities | BUY | – |
No comments yet — be the first to weigh in on RPRX.
Sign in to join the discussion.